OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 78 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $52,609 | +52.1% | 15,161 | +7.4% | 0.00% | – |
Q4 2022 | $34,594 | -66.4% | 14,120 | -62.2% | 0.00% | -100.0% |
Q3 2022 | $103,000 | -63.2% | 37,314 | -45.7% | 0.00% | -50.0% |
Q2 2022 | $280,000 | -30.3% | 68,735 | -27.1% | 0.00% | -33.3% |
Q1 2022 | $402,000 | -49.6% | 94,290 | +10.7% | 0.00% | -62.5% |
Q4 2021 | $797,000 | -30.9% | 85,198 | +103.7% | 0.01% | -46.7% |
Q3 2021 | $1,153,000 | +1821.7% | 41,832 | +1845.7% | 0.02% | +1400.0% |
Q2 2021 | $60,000 | – | 2,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |